Pharmaceutical Characterization of MyoNovin, a Novel Skeletal Muscle Regenerator: in silico, in vitro and in vivo Studies
PURPOSE: MyoNovin is a novel skeletal muscle-regenerating compound developed through synthesis of two nitro groups onto a guaifenesin backbone to deliver nitric oxide to skeletal muscle with a potential to treat muscle atrophy. The purpose of this study was to utilize in silico, in vitro, and in vi...
Main Authors: | Samaa Alrushaid, Neal M. Davies, Judy E. Anderson, Tyson Le, Jaime A. Yáñez, Zaid H. Maayah, Ayman O.S. El-Kadi, Ousama Rachid, Casey L. Sayre, Raimar Löbenberg, Frank J. Burczynski |
---|---|
Format: | Article |
Language: | English |
Published: |
Canadian Society for Pharmaceutical Sciences
2018-03-01
|
Series: | Journal of Pharmacy & Pharmaceutical Sciences |
Online Access: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/29683 |
Similar Items
-
Enhancing the water solubility of MyoNovin - a novel skeletal muscle regenerator
by: Wang, Siyan
Published: (2015) -
Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative
by: Samaa Alrushaid, et al.
Published: (2017-09-01) -
DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways
by: Zaid H. Maayah, et al.
Published: (2018-09-01) -
Stereospecific pharmacokinetic characterization of liquiritigenin in the rat
by: Samaa Alrushaid, et al.
Published: (2017-01-01) -
Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice
by: Samaa Alrushaid, et al.
Published: (2016-01-01)